Ocugen, Inc. Skyrocketed

Fri 05 Feb 21 at 05:30 PM
Ocugen, Inc. Skyrocketed

Ocugen, Inc. (OCGN:NASDAQ) jumped higher at $5.25, representing a gain of 61.5%. On Thu 04 Feb 21, OCGN:NASDAQ hit a New 2-Week Intraday High of $3.69. The stock got featured on our News Catalysts scanner on Fri 05 Feb 21 at 01:46 PM in the 'BIOTECH' category. From Thu 21 Jan 21, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Tue 02 Feb 21 at $3.73 with a volume of 410M+.

About Ocugen, Inc. (OCGN:NASDAQ)

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.